Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial
作者
David J. Jackson,Njira L Lugogo,Mark Gurnell,Liam G Heaney,Stephanie Korn,Guy Brusselle,Pascal Chanez,Ricardo del Olmo,Jean-Pierre Llanos,Nanna Keeling,Kinga Sałapa,Bill Cook,Amit D. Parulekar,Konstantinos Kostikas,Robert Fogel,Neil Martin,Shradha N Chandarana